Mentor Capital Reports 66% 2018 Revenue Increase in 10-K
Posted on Friday March 29, 2019

SAN DIEGO, CA / ACCESSWIRE / March 29, 2019 / Mentor Capital, Inc. (MNTR) announced that it had filed its annual 10-K filing for the year December 31, 2018, with the Securities and Exchange Commission. The Company reports that for the year ended December 31, 2018 Mentor had revenues of $5,281,533 and gross profit of $1,582,599 with a resulting net loss attributable to Mentor of ($409,161) or (1.8 cents) per share. The Mentor Capital, Inc. parent company has no non-affiliate debt and collected a net payment of $1,758,949 on January 23, 2018 in satisfaction of the Company's judgment against Bhang Corporation.

Mentor Capital Turns Profitable on 26% Year on Year Revenue Gains
Posted on Wednesday November 14, 2018

SAN DIEGO, CA / ACCESSWIRE / November 14, 2018 / Mentor Capital, Inc. (MNTR) announced that it had filed its quarterly 10-Q filing for the third quarter ended September 30, 2018, with the Securities and Exchange Commission. For the quarter ended September 30, 2018, Mentor had revenues of $1,031,622 and gross profit of $300,501 with a resulting net income attributable to Mentor of $77,224 or 0.3 cents per share. This is an improvement over the prior year quarter ended September 30, 2017 revenues of $815,102 and gross profit of $289,211, with a resulting net loss attributable to Mentor of ($285,796) or (1.3 cents) per share.

Mentor Capital to Present on the Cannabis Market Thursday, October 4, 2018 at 9:30 (PST) at the OTCQX Virtual Investor Conference
Posted on Monday October 01, 2018

SAN DIEGO, CA / ACCESSWIRE / October 1, 2018 / Mentor Capital, Inc. (OTCQX: MNTR) announced today that it has been invited to present and answer investor questions at the OTCQX® Virtual Investor Conference ...

Mentor Capital Adds Three Cannabis Investments in Two Months
Posted on Friday September 14, 2018

Mentor Capital, Inc. (MNTR) announced that its investment in G FarmaLabs Limited has increased to $2,700,000 following yesterday’s seventh investment tranche delivered to G Farma of $250,000 from Mentor for additional leased equipment and working capital. Nicole Gonzalez, Founder of G FarmaBrands, comments, “With financial backing from Mentor Capital, G FarmaLabs has hit its benchmarks on the way to building cannabis efficient facilities and production lines.” Ata Gonzalez, Co-Founder of G FarmaLabs concludes, “Chet provides both money and a wealth of knowledge. “Mentor Capital focuses new investment from shareholders and other investors on larger cannabis companies, like G Farma, that have the potential to go public and who may be incubated by Mentor along that path,” explained Mentor Capital, Inc. CEO, Chet Billingsley.